Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R I Feldman

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Molecular Pharmacology|March 1, 1996
Gastrin-releasing peptide receptor signaling resulting in growth inhibitionR I Feldman, S Fried, E Mann, et al.
Physiological Genomics|January 5, 2002
Identification of AKT-regulated genes in inducible MERAkt cellsI Kuhn, M F Bartholdi, H Salamon, et al.
International Journal of Cancer|March 12, 1998
In situ hybridization for gastrin-releasing peptide receptor (GRP receptor) expression in prostatic carcinomaM F Bartholdi, J M Wu, H Pu, et al.
Oncogene|May 24, 2000
Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancerZ Q Yuan, M Sun, R I Feldman, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 29, 2013
von Willebrand factor contributes to longer half-life of PEGylated factor VIII in vivoL Tang, L Leong, D Sim, et al.
Cancer Research|August 17, 2001
Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3KM Sun, J E Paciga, R I Feldman, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 15, 1991
Molecular cloning of the bombesin/gastrin-releasing peptide receptor from Swiss 3T3 cellsJ F Battey, J M Way, M H Corjay, et al.
Journal of Thrombosis and Haemostasis : JTH|May 23, 2013
Glycoengineered factor IX variants with improved pharmacokinetics and subcutaneous efficacyA R Brooks, D Sim, U Gritzan, et al.
The American Journal of Pathology|August 4, 2001
AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cellsM Sun, G Wang, J E Paciga, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2000
Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistryK McMillan, M Adler, D S Auld, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Molecular Pharmacology|March 1, 1996
Gastrin-releasing peptide receptor signaling resulting in growth inhibitionR I Feldman, S Fried, E Mann, et al.
Physiological Genomics|January 5, 2002
Identification of AKT-regulated genes in inducible MERAkt cellsI Kuhn, M F Bartholdi, H Salamon, et al.
International Journal of Cancer|March 12, 1998
In situ hybridization for gastrin-releasing peptide receptor (GRP receptor) expression in prostatic carcinomaM F Bartholdi, J M Wu, H Pu, et al.
Oncogene|May 24, 2000
Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancerZ Q Yuan, M Sun, R I Feldman, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 29, 2013
von Willebrand factor contributes to longer half-life of PEGylated factor VIII in vivoL Tang, L Leong, D Sim, et al.
Cancer Research|August 17, 2001
Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3KM Sun, J E Paciga, R I Feldman, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 15, 1991
Molecular cloning of the bombesin/gastrin-releasing peptide receptor from Swiss 3T3 cellsJ F Battey, J M Way, M H Corjay, et al.
Journal of Thrombosis and Haemostasis : JTH|May 23, 2013
Glycoengineered factor IX variants with improved pharmacokinetics and subcutaneous efficacyA R Brooks, D Sim, U Gritzan, et al.
The American Journal of Pathology|August 4, 2001
AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cellsM Sun, G Wang, J E Paciga, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2000
Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistryK McMillan, M Adler, D S Auld, et al.
Pageof 3